Anti-OX40L antibodies
This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Endl, Joseph Eugui, Elsie M Fuentes, Maria Elena Graus, Yvo Labrijn, Aran Frank Lanzendoerfer, Martin Parren, Paul Rebers, Frank Schumacher, Ralf Seeber, Stefan Van De Winkel, Jan Van Vugt, Martine |
| description | This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07501496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07501496</sourcerecordid><originalsourceid>FETCH-uspatents_grants_075014963</originalsourceid><addsrcrecordid>eNrjZBB1zCvJ1PWPMDHwUUgEMpPyUzJTi3kYWNMSc4pTeaE0N4OCm2uIs4duaXFBYklqXklxfHpRIogyMDc1MDSxNDMmQgkADkghPA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-OX40L antibodies</title><source>USPTO Issued Patents</source><creator>Endl, Joseph ; Eugui, Elsie M ; Fuentes, Maria Elena ; Graus, Yvo ; Labrijn, Aran Frank ; Lanzendoerfer, Martin ; Parren, Paul ; Rebers, Frank ; Schumacher, Ralf ; Seeber, Stefan ; Van De Winkel, Jan ; Van Vugt, Martine</creator><creatorcontrib>Endl, Joseph ; Eugui, Elsie M ; Fuentes, Maria Elena ; Graus, Yvo ; Labrijn, Aran Frank ; Lanzendoerfer, Martin ; Parren, Paul ; Rebers, Frank ; Schumacher, Ralf ; Seeber, Stefan ; Van De Winkel, Jan ; Van Vugt, Martine ; Roche Palo Alto LLC</creatorcontrib><description>This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.</description><language>eng</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7501496$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,778,800,883,64024</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7501496$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Endl, Joseph</creatorcontrib><creatorcontrib>Eugui, Elsie M</creatorcontrib><creatorcontrib>Fuentes, Maria Elena</creatorcontrib><creatorcontrib>Graus, Yvo</creatorcontrib><creatorcontrib>Labrijn, Aran Frank</creatorcontrib><creatorcontrib>Lanzendoerfer, Martin</creatorcontrib><creatorcontrib>Parren, Paul</creatorcontrib><creatorcontrib>Rebers, Frank</creatorcontrib><creatorcontrib>Schumacher, Ralf</creatorcontrib><creatorcontrib>Seeber, Stefan</creatorcontrib><creatorcontrib>Van De Winkel, Jan</creatorcontrib><creatorcontrib>Van Vugt, Martine</creatorcontrib><creatorcontrib>Roche Palo Alto LLC</creatorcontrib><title>Anti-OX40L antibodies</title><description>This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZBB1zCvJ1PWPMDHwUUgEMpPyUzJTi3kYWNMSc4pTeaE0N4OCm2uIs4duaXFBYklqXklxfHpRIogyMDc1MDSxNDMmQgkADkghPA</recordid><startdate>20090310</startdate><enddate>20090310</enddate><creator>Endl, Joseph</creator><creator>Eugui, Elsie M</creator><creator>Fuentes, Maria Elena</creator><creator>Graus, Yvo</creator><creator>Labrijn, Aran Frank</creator><creator>Lanzendoerfer, Martin</creator><creator>Parren, Paul</creator><creator>Rebers, Frank</creator><creator>Schumacher, Ralf</creator><creator>Seeber, Stefan</creator><creator>Van De Winkel, Jan</creator><creator>Van Vugt, Martine</creator><scope>EFH</scope></search><sort><creationdate>20090310</creationdate><title>Anti-OX40L antibodies</title><author>Endl, Joseph ; Eugui, Elsie M ; Fuentes, Maria Elena ; Graus, Yvo ; Labrijn, Aran Frank ; Lanzendoerfer, Martin ; Parren, Paul ; Rebers, Frank ; Schumacher, Ralf ; Seeber, Stefan ; Van De Winkel, Jan ; Van Vugt, Martine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_075014963</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Endl, Joseph</creatorcontrib><creatorcontrib>Eugui, Elsie M</creatorcontrib><creatorcontrib>Fuentes, Maria Elena</creatorcontrib><creatorcontrib>Graus, Yvo</creatorcontrib><creatorcontrib>Labrijn, Aran Frank</creatorcontrib><creatorcontrib>Lanzendoerfer, Martin</creatorcontrib><creatorcontrib>Parren, Paul</creatorcontrib><creatorcontrib>Rebers, Frank</creatorcontrib><creatorcontrib>Schumacher, Ralf</creatorcontrib><creatorcontrib>Seeber, Stefan</creatorcontrib><creatorcontrib>Van De Winkel, Jan</creatorcontrib><creatorcontrib>Van Vugt, Martine</creatorcontrib><creatorcontrib>Roche Palo Alto LLC</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Endl, Joseph</au><au>Eugui, Elsie M</au><au>Fuentes, Maria Elena</au><au>Graus, Yvo</au><au>Labrijn, Aran Frank</au><au>Lanzendoerfer, Martin</au><au>Parren, Paul</au><au>Rebers, Frank</au><au>Schumacher, Ralf</au><au>Seeber, Stefan</au><au>Van De Winkel, Jan</au><au>Van Vugt, Martine</au><aucorp>Roche Palo Alto LLC</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-OX40L antibodies</title><date>2009-03-10</date><risdate>2009</risdate><abstract>This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07501496 |
| source | USPTO Issued Patents |
| title | Anti-OX40L antibodies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T20%3A20%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Endl,%20Joseph&rft.aucorp=Roche%20Palo%20Alto%20LLC&rft.date=2009-03-10&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07501496%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |